Latest Redmile Group, LLC Stock Portfolio
$1.51Billion– No. of Holdings #35
Redmile Group, LLC Performance:
2026 Q1: 0.17%YTD: 0.17%2025: 39.74%
Performance for 2026 Q1 is 0.17%, and YTD is 0.17%, and 2025 is 39.74%.
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $1.5 Billions as of 31 Mar, 2026.
The top stock holdings of Redmile Group, LLC are SRRK, KRYS, STOK. The fund has invested 29.5% of it's portfolio in SCHOLAR ROCK HLDG CORP and 11.5% of portfolio in KRYSTAL BIOTECH INC.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT), REPLIMUNE GROUP INC (REPL) and REPARE THERAPEUTICS INC (RPTX) stocks. They significantly reduced their stock positions in PLIANT THERAPEUTICS INC (PLRX), COGENT BIOSCIENCES INC (COGT) and IDEAYA BIOSCIENCES INC (IDYA). Redmile Group, LLC opened new stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), PRIME MEDICINE INC and ARDELYX INC (ARDX). The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO), XENON PHARMACEUTICALS INC (XENE) and SCHOLAR ROCK HLDG CORP (SRRK).
The top stock holdings of Redmile Group, LLC are SRRK, KRYS, STOK. The fund has invested 29.5% of it's portfolio in SCHOLAR ROCK HLDG CORP and 11.5% of portfolio in KRYSTAL BIOTECH INC.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT), REPLIMUNE GROUP INC (REPL) and REPARE THERAPEUTICS INC (RPTX) stocks. They significantly reduced their stock positions in PLIANT THERAPEUTICS INC (PLRX), COGENT BIOSCIENCES INC (COGT) and IDEAYA BIOSCIENCES INC (IDYA). Redmile Group, LLC opened new stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), PRIME MEDICINE INC and ARDELYX INC (ARDX). The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO), XENON PHARMACEUTICALS INC (XENE) and SCHOLAR ROCK HLDG CORP (SRRK).
Redmile Group, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of 0.17% in the last quarter. In trailing 12 months, it's portfolio return was 81.04%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| biomarin pharmaceutical inc | 9,821,300 |
| prime medicine inc | 5,536,100 |
| eupraxia pharmaceuticals inc | 5,068,000 |
| ardelyx inc | 4,392,770 |
| agomab therapeutics nv | 1,639,060 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| alx oncology hldgs inc | 143 |
| xenon pharmaceuticals inc | 96.2 |
| scholar rock hldg corp | 73.66 |
| annexon inc | 44.76 |
| solid biosciences inc | 8.13 |
| stoke therapeutics inc | 3.22 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| pliant therapeutics inc | -52.23 |
| cogent biosciences inc | -52.15 |
| ideaya biosciences inc | -29.77 |
| ceribell inc | -11.13 |
| dbv technologies s a | -10.64 |
| livanova plc | -8.22 |
| establishment labs hldgs inc | -8.17 |
| celldex therapeutics inc new | -7.69 |
Redmile Group, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| repare therapeutics inc | -4,124,050 |
| replimune group inc | -10,689,600 |
| rapt therapeutics inc | -30,006,300 |
| kalaris therapeutics inc | -700,140 |
Redmile Group, LLC got rid off the above stocks
Sector Distribution
Redmile Group, LLC has about 91.1% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 91.1 |
| Others | 8.6 |
Market Cap. Distribution
Redmile Group, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 56.5 |
| SMALL-CAP | 29.6 |
| UNALLOCATED | 8.6 |
| MICRO-CAP | 4.5 |
Stocks belong to which Index?
About 76.2% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 76.2 |
| Others | 23.8 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 35 stocks in it's portfolio. About 81.9% of the portfolio is in top 10 stocks. NRIX proved to be the most loss making stock for the portfolio. SRRK was the most profitable stock for Redmile Group, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 1.64 | 8,253,320 | 24,759,900 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 3.84 | 15,470,500 | 58,014,400 | reduced | -1.25 | ||
| ADGI | invivyd inc | 0.23 | 2,648,660 | 3,443,260 | reduced | -1.21 | ||
| ALXO | alx oncology hldgs inc | 1.06 | 7,964,190 | 15,968,200 | added | 143 | ||
| ANNX | annexon inc | 5.34 | 14,549,800 | 80,605,700 | added | 44.76 | ||
| ARDX | ardelyx inc | 0.29 | 733,350 | 4,392,770 | new | |||
| ATRA | atara biotherapeutics inc | 0.14 | 441,701 | 2,089,250 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 1.95 | 1,237,660 | 29,493,400 | reduced | -3.75 | ||
| BMRN | biomarin pharmaceutical inc | 0.65 | 173,859 | 9,821,300 | new | |||
| CLDX | celldex therapeutics inc new | 0.55 | 261,508 | 8,295,030 | reduced | -7.69 | ||
| COGT | cogent biosciences inc | 1.75 | 688,036 | 26,482,500 | reduced | -52.15 | ||
| DBVT | dbv technologies s a | 0.68 | 491,340 | 10,264,100 | reduced | -10.64 | ||
| ESTA | establishment labs hldgs inc | 0.39 | 103,464 | 5,874,690 | reduced | -8.17 | ||
| FATE | fate therapeutics inc | 1.02 | 12,872,900 | 15,447,500 | unchanged | 0.00 | ||
| IDYA | ideaya biosciences inc | 1.15 | 521,117 | 17,363,600 | reduced | -29.77 | ||
| IMNM | immunome inc | 8.05 | 5,558,880 | 121,573,000 | reduced | -2.79 | ||
| KRYS | krystal biotech inc | 11.52 | 673,505 | 173,980,000 | reduced | -0.62 | ||
| LIVN | livanova plc | 0.46 | 108,354 | 6,886,980 | reduced | -8.22 | ||
| NRIX | nurix therapeutics inc | 7.94 | 7,732,810 | 119,859,000 | reduced | -4.46 | ||
| NUVB | nuvation bio inc | 0.90 | 3,153,260 | 13,527,500 | reduced | -0.32 | ||